Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its coverage of NeuroStar® …
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression Read More
PHOENIXVILLE, PA — Facet Life Sciences has been selected as the U.S. regulatory partner for Cybin Inc., a neuropsychiatry company focused on innovative mental health treatments. This collaboration aims to accelerate …
Facet Life Sciences Partners with Cybin to Advance Mental Health Therapies Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced significant progress in expanding access to its NeuroStar TMS Therapy for patients with major depressive disorder (MDD).
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment Read More
MALVERN, PA — In recognition of Suicide Prevention Month, Neuronetics, Inc. (NASDAQ: STIM) is spotlighting the impactful stories shared on its NeuroStar Voices Portal. This platform, launched last year, allows individuals …
Neuronetics’ Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide Rates Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that California Medicaid, known as Medi-Cal, will now cover transcranial magnetic stimulation (TMS) for both adults and adolescents aged 15 and older …
Neuronetics Secures Medi-Cal Coverage for TMS Treatment in California Read MoreMALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced significant updates from major insurers that will broaden access to transcranial magnetic stimulation (TMS) for younger patients. BlueCross BlueShield (BCBS) of …
Expanded Insurance Coverage Boosts Access to TMS Treatment for Adolescents Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced that the U.S. Food and Drug Administration (FDA) has cleared NeuroStar TMS (transcranial magnetic stimulation) for use as a first-line add-on …
FDA Clears NeuroStar TMS Therapy for Adolescents with Depression, A First in the Field Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the publication of a groundbreaking study in the prestigious journal Brain Stimulation. The research provides new insights into the effectiveness of …
New Study Offers Hope for Depression Patients Undergoing TMS Therapy Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), the makers of NeuroStar Advanced Therapy, recently announced vital healthcare policy updates from Magellan, BlueCross BlueShield (BCBS) of Kansas City, and Dean Health …
Neuronetics Gets Healthcare Policy Boost: Increased Patient Access to NeuroStar Therapy Read More
Seasonal depression, also known as Seasonal Affective Disorder (SAD), is a type of depression that comes and goes with the seasons. Typically, it starts in late fall and early winter …
Unmasking Seasonal Depression: Hacks to Brighten Your Mood Read More